Development of cerium oxide nanoparticles and its cytotoxicity in prostate cancer cells

Advanced Science Letters

Volumn 6, Issue , 2012, Pages 17-25

  Renu, G ^a   Divya Rani, V V ^a   Nair, S V ^a   Subramanian, K R V ^a   Lakshmanan, Vinoth Kumar ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cellular uptake; Cerium oxide nanoparticles; Cytotoxicity; Hydrothermal; MTT assay; Prostate cancer cell line; Stoichiometry

Indexed keywords

EID: 84861517526     PISSN: 19366612     EISSN: 19367317     Source Type: Journal    
DOI: 10.1166/asl.2012.3312     Document Type: Article

References (51)

1. H. Bu, S. Bormann, G. Schafer, W. Horninger, P. Massoner, A. Neeb, V. K. Lakshmanan, D. Maddalo, A. Nestl, H. Sultmann, A. C. B. Cato, and H. Klocker, The anteriorgradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. The Prostate 71, 575 (2011).
2. L. E. van Vlerken and M. M. Amiji, Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin. Drug Deliv. 3, 205 (2006).
3. H. S. Nalwa and T. Webster (eds.), Cancer Nanotechnology-Nanomaterials for Cancer Diagnosis and Therapy, American Scientific Publishers, Los Angeles (2007).
4. Y. L. Zhao and H. S. Nalwa (eds.), Nanotoxicology-Interactions of Nanomaterials with Biological Systems, American Scientific Publishers, Los Angeles (2007).
5. S. Singh and H. S. Nalwa, Nanotechnology and health safety-toxicity and risk assessments of nanostructured materials on human health. J. Nanosci. Nanotechnol. 7, 3048 (2007).
6. S. Singh, Nanomedicine-Nanoscale Drugs and Delivery Systems, J. Nanosci. Nanotechnol. 10, 7906 (2010).
7. R. Singh and H. S. Nalwa, Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J. Biomed. Nanotechnol. 7, 489 (2011).
8. P. Ayyub, V. R. Palkar, S. Chattopadhyay, and M. Multani, Effect of crystal size reduction on lattice symmetry and cooperative properties. Phys. Rev. B 51, 6135 (1995).
9. M. Fernandez-Garci{dotless}a, A. Marti{dotless}nez-Arias, J. C. Hanson, and J. A. Rodríguez, Nanostructured Oxides in Chemistry: Characterization and Properties. Chem. Rev. 104, 4063 (2004).
10. Z. Y. Hu, S. Haneklaus, G. Sparovek, and E. Schnug, Rare earth elements in soils. Commun. Soil Sci. Plan. 37, 1381 (2006).
11. A. Medalia and B. Byrne, Spectrophotometric determination of of cerium (IV). Anal. Chem. 23, 453 (1951).
12. Y. Zhang, S. Andersson, and M. Muhammed, Nanophase catalytic oxides: I. Synthesis of doped cerium oxides as oxygen storage promoters. Appl. Catal B: Environmental. 6, 325 (1995).
13. F. E. Livingston, P. M. Adams, and H. Helvajian, Influence of cerium on the pulsed UV nanosecond laser processing of photostructurable glass ceramic materials. Appl. Surf. Sci. 247, 526 (2005).
14. R. N. Blumenthal and J. E. Garnier, The electrical conductivity and thermodynamic behavior of SrO-doped nonstoichiometric cerium dioxide: Metallurgy and Materials Science. J. Solid State Chem. 15, 103 (1975).
15. M. Brendily-Anne, J. Lumeau, L. Glebova, and B. G. Leonoid, Specific absorption spectra of cerium in multicomponent silicate glasses. J. Non-Cryst Solids 356, 2337 (2010).
16. R. I. Sheldon, G. H. Rinehart, S. Krishnan, and P. C. Nordine, The optical properties of liquid cerium at 632.8 nm. Mat. Sci. Eng. B 79, 113 (2001).
17. M. Abecassis-Wolfovich, R. Jothiramalingam, M. V. Landau, M. Herskowitz, B. Viswanathan, and T. K. Varadarajan, Cerium incorporated ordered manganese oxide OMS-2 materials: Improved catalysts for wet oxidation of phenol compounds. Appl. Catal B 59, 91 (2005).
18. A. Martinez-Arias, A. B. Hungria, M. Fernandez-Garcia, A. Iglesias-Juez, J. C. Conesa, G. C. Mather, and G. Munuera, Cerium-terbium mixed oxides as potential materials for anodes in solid oxide fuel cells. J. Power Sour. 151, 43 (2005).
19. N. Rhys-Jones, H. J. Grabke, and H. Kudielka, The effects of various amounts of alloyed cerium and cerium oxide on the high temperature oxidation of Fe-10Cr and Fe-20Cr alloys. Corros. Sci. 27, 49 (1987).
20. P. Kaminski, T. Suzuki, and H. U. Anderson, Nanocrystalline undoped ceria oxygen sensor. Sensors Actuat B-Chem. 95, 73 (2003).
21. 2_: Performance improvement during long-time irradiation. Sol. Energ. Mat. Sol C 90, 2076 (2006).
22. A. Tschope, W. Liu, F. Stephanopoulos, and Y. Y. Jackie, Redox activity of nonstoichometric cerium oxide based nanocrystalline catalysts. J. Catal. 157, 42 (1995).
23. I. Celardo, E. Traversa, and L. Ghibelli, Cerium oxide nanoparticles: A promise for applications in therapy. J. Exp Ther Oncol. 9, 47 (2011).
24. T. Skala, F. Sutara, K. C. Prince, and V. Matolin, Cerium oxide stoichiometry alteration via Sn deposition: Influence of temperature. J. Electron Spectrosc. 169, 20 (2009).
25. M. Das, S. Patil, N. Bhargava, J. Kang, M. Lisa, Riedel, S. Seal, and J. J. Hickman, Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28, 1918 (2007).
26. J. Chen, S. Patil, S. Seal, and J. F. McGinnis, Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nano 1, 142 (2006).
27. A. S. Karakoti, N. A. Monteiro-Riviere, R. Aggarwal, J. P. Davis, R. J. Narayan, W. T. Self, J. McGinnis, and S. Seal, Nanoceria as antioxidant: Synthesis and biomedical applications. JOM 60, 33 (2008).
28. S. Patil, S. Amanda, H. Eric, W. T. Self, and S. Seal, Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28, 4600 (2007).
29. I. Celardo, J. Z. Pedersen, E. Traversa, and L. Ghibelli, Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 3, 1411 (2011).
30. I. A. Gamaley, I. V. Klyubin, Roles of reactive oxygen species: Signaling and regulation of cellular functions. Int. Rev. Cytol. 188, 203 (1999).
31. L. Magdalena, Circu, and Y. A. Tak, Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical. Bio Med. 48, 749 (2010).
32. S. Babu, V. Anthony, W. Krzysztof, S. Jadwiga, and S. Seal, Electron paramagnetic study on radical scavenging properties of ceria nanoparticles. Chem. Phys. Lett. 442, 405 (2007).
33. C. Korsvik, S. Patil, S. Seal, and W. T. Self, Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (Camb) 14, 1056 (2007).
34. M. Hirano and E. Kato, Microwave-assisted synthesis of ceria nanoparticles. J. Mater. Sci. Lett. 8, 1249 (1996).
35. J. Hongyun, W. Ning, X. Liang, and H. Shuen, Synthesis and conductivity of cerium oxide nanoparticles. Mater Lett. 64, 1254 (2010).
36. M. Palard, J. Balencie, A. Maguer, and J. Hochepied, Effect of hydrothermal ripening on the photoluminescence properties of pure and doped cerium oxide nanoparticles. Mater. Chem. Phys. 120, 79 (2010).
37. N. Moloto, N. Revaprasadu, and P. L. Musetha, The effect of precursor concentration, temperature and capping group on the morphology of CdS nanoparticles. J. Nanosci. Nanotechnol. 9, 4760 (2009).
38. 2nano-particles. Mater. Process. Tech. 190, 217 (2007).
39. E. G. Heckert, A. S. Karakoti, S. Seal, and W. T. Self, The role of cerium redox state in the SOD mimetic activity of Nanoceria. Biomaterials 29, 2705 (2008).
40. J. Colon, N. Hsieh, A. Ferguson, P. Kupelian, S. Seal, D. W. Jenkins, and C. H. Baker, Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 6, 698 (2010).
41. J. Niu, A. Azfer, L. M. Rogers, X. Wang, and P. E. Kolattukudy, Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res. 73, 549 (2007).
42. W. Lin, Y. W. Huang, X. D. Zhou, and Y. Ma, Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int. J. Toxicol. 25, 451 (2006).
43. A. Asati, S. Santra, C. Kaittanis, and J. M. Perez, Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 4, 5321 (2010).
44. A. S. Arbab, L. A. Bashaw, B. R. Miller, E. K. Jordan, B. K. Lewis, and H. Kalish, Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles andtransfection agent for cellular MR imaging. Radiology 229, 838 (2003).
45. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Delivery Rev. 55, 329 (2003).
46. L. Mu and S. S. Feng, A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R): PLGA nanoparticles containing vitamin E TPGS. J. Controlled Release 86, 33 (2003).
47. K. Y. Win and S. S. Feng, Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 2713 (2005).
48. M. R. Lorenz, V. Holzapfel, A. Musyanovych, K. Nothelfer, P. Walther, H. Frank, K. Landfester, H. Schrezenmeier, and V. Mailander, Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27, 2820 (2006).
49. C. Wilhelm, C. Billotey, J. Roger, J. N. Pons, J. Bacri, and F. Gazeau, Intracellular uptake of anionic super paramagnetic nanoparticles as a function of their surface coating. Biomaterials 2, 1001 (2003).
50. L. K. Limbach, Y. Li, R. N. Grass, T. J. Brunner, M. A. Hintermann, and M. Muller, Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 39, 9370 (2005).
51. M. P. Murphy and R. Smith, Drug delivery to mitochondria: The key to mitochondrial medicine. Adv. Drug Delivery Rev. 41, 235 (2000).